Autoplaque vs Eko Murmur Analysis Software (EMAS)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by APQ Health (formerly Cedars-Sinai Medical Center: AIM)
VS

AI Verdict

Autoplaque focuses on the quantitative analysis of coronary plaques and luminal stenoses from CT angiography images to aid in heart attack risk prediction. In contrast, Eko Murmur Analysis Software (EMAS) utilizes AI with digital stethoscopes to detect and differentiate heart murmurs from heart sounds. While both are FDA-cleared AI tools in cardiology, they address different diagnostic pathways and utilize distinct data sources for their analyses.

Choose Autoplaque if…

Choose Autoplaque if your primary need is a detailed, quantitative assessment of coronary artery disease based on CT angiography images. This tool is ideal for cardiologists and radiologists who require precise measurements of plaque burden and luminal stenosis to refine heart attack risk prediction and guide interventional strategies. It excels in post-processing existing imaging data for comprehensive diagnostic insights.

View Autoplaque →

Choose Eko Murmur Analysis Software (EMAS) if…

Choose Eko Murmur Analysis Software (EMAS) if you need an accessible, AI-powered tool for real-time detection and differentiation of heart murmurs during a physical examination. This solution is best suited for primary care physicians, pediatricians, and internal medicine specialists seeking to quickly screen patients for potential cardiac conditions using a digital stethoscope. It provides immediate clinical decision support at the point of care.

View Eko Murmur Analysis Software (EMAS) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Autoplaque Eko Murmur Analysis Software (EMAS)
Pricing Unknown Starts at $119.99 per year for eko+ membership; enterprise solutions require contacting sales.
Deployment Workstation-based post-processing application, runs on Windows or Mac OS. Cloud-based, Mobile App
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Murmur Analysis Software (EMAS)

Eko Murmur Analysis Software (EMAS) offers a more flexible and immediate user experience through its cloud-based mobile application and wireless Bluetooth connectivity, integrating directly with Eko digital stethoscopes at the point of care. Autoplaque, being workstation-based software, while offering detailed analysis, may require a more dedicated setup and could be less agile in various clinical settings.

Clinical Value

Autoplaque

Autoplaque provides highly specific, quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, directly aiding in heart attack risk prediction and treatment guidance for a leading cause of mortality. While EMAS offers valuable early detection and differentiation of heart murmurs across a broader patient population, Autoplaque's deep, quantitative insights from advanced imaging offer a more definitive and actionable diagnostic contribution for advanced disease management.

Pricing & Value

Eko Murmur Analysis Software (EMAS)

EMAS clearly wins this dimension by offering transparent pricing, including a free basic AI analysis option with the Eko App and tiered paid subscriptions for full features and telehealth capabilities. Autoplaque's pricing information is not disclosed, making it impossible to assess its value proposition.

Enterprise Readiness

Eko Murmur Analysis Software (EMAS)

EMAS demonstrates stronger enterprise readiness with explicit statements of HIPAA compliance and the availability of a Business Associate Agreement (BAA). Its cloud-based deployment, mobile application access, and PDF report generation with EHR compatibility further facilitate integration into diverse healthcare IT environments.

Innovation

Autoplaque

Autoplaque showcases a higher degree of innovation through its sophisticated AI-powered quantitative analysis of complex CT angiography data for detailed plaque characterization and stenosis measurement. This deep analytical capability for a critical and complex cardiovascular condition represents a significant advancement in diagnostic imaging.

Support & Docs

Eko Murmur Analysis Software (EMAS)

Eko Devices, as a commercial entity, provides comprehensive support resources including a dedicated Help Center, user manuals, FAQs, email support, and scheduled phone calls. Autoplaque, originating from a medical center's research division, does not have readily available public documentation or a formalized support structure, suggesting less accessible support for external users.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Autoplaque Eko Murmur Analysis Software (EMAS)
Name Autoplaque Eko Murmur Analysis Software (EMAS)
Company Cedars-Sinai Medical Center: AIM Eko Devices
Primary Function AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. AI tool for detection and differentiation of heart murmurs in adult and pediatric patients.
Key Analysis Type Quantitative analysis of atherosclerotic plaque and measurement of luminal stenoses. Analyzes heart sound (PCG) and optional ECG data to differentiate innocent and structural heart murmurs.
Specialties Cardiology, Radiology Cardiology, Internal Medicine, Pediatrics

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and Eko Murmur Analysis Software (EMAS).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Autoplaque is an AI-powered software designed for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. EMAS is an AI tool that integrates with Eko digital stethoscopes to detect and differentiate heart murmurs in adult and pediatric patients, providing clinical decision support for early detection of heart and lung disease.
Autoplaque requires CT angiography images for its AI-powered quantitative analysis of coronary anatomy and pathology. EMAS analyzes heart sound (PCG) and optional ECG data captured using Eko digital stethoscopes.
Autoplaque is intended for Cardiology and Radiology specialists, focusing on the analysis of coronary plaque and stenosis in patients from CT angiography images. EMAS is designed for Cardiology, Internal Medicine, and Pediatrics, supporting both adult and pediatric patients for murmur detection.
Autoplaque provides AI-powered quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, and measurement of luminal stenoses, with automated segmentation that clinicians can review and edit. EMAS offers FDA-cleared AI for murmur detection, differentiation of innocent and structural heart murmurs, and clinical decision support, with features like recording, playback, and PDF report generation.
EMAS explicitly states it has a Business Associate Agreement (BAA) and is HIPAA compliant, with a pricing model that includes free basic AI analysis and paid subscriptions for full features. Autoplaque does not specify information regarding BAA, HIPAA compliance, or pricing.

Backers

Who funded each tool's parent company.

Eko Murmur Analysis Software (EMAS)

AI Tool Finder
AI-powered search. Results may not be comprehensive.